AMSBIO has announced a new range of expression ready lentiviral particles that allow easy gene delivery into hard to transfect cells including primary cells, non-dividing cells and cells in suspension.

AMSBIO lentiviral particles are supplied ready-to-use eliminating the need for any lipids or transfection reagents.  The range of pre-made lentiviral particles are proven to deliver genes in a highly reproducible and controllable manner for the expression of  greater than 250 human proteins, mouse proteins, enzymes and fluorescent markers. Using proprietary protocols based upon co-expressed red fluorescent protein by a 2A peptide processing (SureTiter^TM) or RSV promoter (Inducible system) - AMSBIO lentiviral particles enable real-time monitoring of protein expression.

Applications that will benefit from lentiviral particles include gene delivery for expression or knock-down in hard-to-transfect cell types such as primary cells, stem cells, drug-arrested cells and cells in suspension. AMSBIO lentiviral particles can also be used to easily and cost effectively create stable cell lines for long-term high constitutive or Tet inducible expression applications in the presence of TetR (a repressor protein). Further, AMSBIO lentiviral particles can also be used in-vivo for the generation of transgenic animals and for inducing pluripotent stem cells (iPSC). Custom lentiviral particles for the expression of your own gene of interest or shRNA can also be generated.

All AMSBIO lentiviral products are easy and safe to use, simply add the high titre particles (1 x 107 IFU/ml or higher) to cultured cells, and you will be able to confirm the specific target's expression under a fluorescent microscope after 48-72 hours.  AMSBIO lentiviral particles are packaged in culture medium with 10% FBS, in serum-free medium or concentrated in PBS for in vivo use.

For further information visit http://www.amsbio.com/expression-ready-lentiviral-particles.aspx or contact AMSBIO on tel. +44-1235-828200

Founded in 1987, AMS Biotechnology (AMSBIO) is recognised as a leading international provider of unique & innovative products & custom services for life sciences research. The AMSBIO range includes over 23,000 polyclonal & monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, & tissue DNA, RNA, protein & microarray products. Key research areas include: apoptosis, cell invasion & migration, cell signaling, DNA damage, electrophoresis, glycobiology, posttranslational modification & stem cell biology.